ConductScience.org, home

Gene · 85340

NIH grants1,373

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleKRT90P papersNewest fiscal year
R01HD072929Optimal Oxygenation in Neonatal Lung Injury22025
R01HL131941Role of Cytoglobin in the Regulation of Vascular Tone22025
R01HL158076Aerosolized therapy for hemoglobin toxicity in the treatment of hemolytic diseases22025
R24AA019431Monkey Alcohol Tissue Research Resource (MATRR)22025
R35GM134744Epigenetic regulations of DNA and histone methylation and deMethylation: Structures and Mechanisms22025
R35GM147400Elucidating biophysical mechanisms for force sensing and control using non-equilibrium statistical mechanics and AI22025
R44HL140739Affordable, quantitative, point-of-care microchip-electrophoresis for screening and treatment monitoring of sickle cell disease, thalassemias, and anemias22025
T32CA009172Physician Scientist Training in Cancer Research22025
T32HL110841Children's Research Institute Hematology Research Training Grant22025
TL1TR002382J. NRSA Training Core22025
U24HL135881Sickle Pan-African Research Consortium Clinical Coordinating Center (SPARCO Center)22025
U24NS107230Mid-America Regional Coordinating Center (MARCC)22025
U54MD007602Center for Translational Research in Health Disparities22025
UL1TR002345Washington University Institute of Clinical and Translational Sciences22025
ZIAAI000483Malaria Drug Resistance and Disease Virulence22025
ZIAAI001020Host Immune Responses to Antigens of Malaria Parasites22025
ZIAAI001155Mechanisms of naturally-acquired immunity to malaria and clinical trials of anti-malaria monoclonal antibodies22025
ZIACL002119Develop novel assays for assessing cellular and gene therapies22025
ZIADK025016Control Of the Human Erythrocytic Hemoglobin Phenotype and Approaches to the Therapy of Sickle Cell Disease22025
ZIADK075033Chromatin Structure, Epigenetic and Developmental Regulation of Mammalian Gene22025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/85340/grants?page=3